Routine dematerialization compliance certificate for Q2 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹34.48

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+2.7% vs market

Pharmaceuticals peers, median of 168sector-0.3%+3.2% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 3.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9+0.2+2.7-0.3+3.2

Next day

-5.1+0.9-6.0-0.3-4.8

-2.7-0.8-1.9-1.2-1.5

-2.3-0.1-2.2-1.0-1.3

-10.1-1.7-8.4-2.6-7.5

-13.1-4.3-8.8-3.8-9.2

-13.0-7.5-5.5-6.4-6.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kimia Biosciences submitted a compliance certificate under SEBI Regulation 74(5) for Q2 FY27 (quarter ended 30 September 2026). RTA Beetal Financial confirms all securities received for dematerialization were confirmed to depositories. Physical certificates were cancelled and depository names substituted in the register of members within 15 days. This is a routine procedural filing.

Likely market impact

No material impact. Routine SEBI compliance filing related to share dematerialization with no business or financial significance.